Andrew Syritsa

Doctor of the highest category, obstetrician-gynecologist
Conducts 3D/4D ultrasound diagnostics
Engaged in infertility treatment, artificial insemination, manages the organization of the clinic.

Education:

• 2 Haapsalu School in 1978
• UT Faculty of Medicine 1984
• 1990 Candidate of Medical Sciences (Minsk State Medical Institute)
• Advanced training in Finland, Sweden, Denmark, Germany, France, USA, South Africa, Australia, Switzerland, England, Iceland, Italy, the Netherlands, Austria.

Experience:

• 1984-88 Umpi-V laboratory,
• 1988-89 UT Department of Obstetrics and Gynecology junior researcher,
• Doctor 1989-92, 1992-98, UT Women's Clinic doctor
• 1998 - 2007 Associate Professor and Head of Private Practice and Doctor
• Elite 2001 from the owner of a private clinic and a doctor
• Gyne Clinic and Gyne Johvi owner.

Scientific activity:

• Lectures of the University of Tartu, obstetrics and gynecology.
• Research area: diagnostics and treatment of infertility, assisted reproductive technologies, gynecology, diagnostic methods;
• The first artificially conceived child was born in the Baltic States (1995).
• He has spoken at many international conferences.
• In 1997, the charity event "A Child in Every Family"
• Member of the Nadezhda Foundation (1992-1996 - President of the Foundation), Member of the Bioethics Council in Estonia (1998-2001), Estonian Red Cross Order of Merit II (2006).

Publications and literature:

• Laparoscopic evaluation of the causes of infertility (co-author). / / Research in Medicine. Trt, 1993;
• Prognostic factors for IVF (co-author). / / EA (1998) 1;
• Transvaginal ultrasound-guided electrocoagulation in infertile patients with polycystic ovary syndrome. / / Int. J. Gynecol. And Obstetrics 63 (1998) 3;
• Development and formation of blastocyst in normal and low-quality polypoid embryos (co-author). / / Human Reprod. 14 (1999);
• Embryo, IVF procedure (co-author). / / E.A., 79 (2000) 7;
• Use of recombinant gonadotropins in IVF (co-author). / / E.A., 79 (2000) 9;
• The importance of implantation, fertilization outside the body (co-author S. Kalm). / / E.A., 80 (2001) 3;
• Use of recombinant follicle-stimulating hormone containing treatment of infertility (co-author S. Kalm). / / E.A., 81 (2002), 5;
• Plasma Total Homocysteine Concentrations in Infertile Women Compared with Adult Control Values (Co-authors T. Panova, T. Reitsnik). / / Clinic Chimica Acta 355 (2005);
• The girl was born through in vitro fertilization with a rather rare disease - / incontinentia pigment / (co-author). / / E.A. 87 (2008)
• Incontinentia pigment in femal conceived in vitro fertilization. Haller Kikkatalo-K, Peters M, Kisand K, Sõritsa Reimand T, Salumets A.
• Am J Med Gene A. 2008 Feb 1;146A(23):3092-4
• Poster UT Faculty of Medicine, 2010 and 2011. Scientific conferences (co-author), information published in the journal "Africa Doctor".
• Poster presentations Inimesegeentika Society of Ireland in 2010. J. Conference (co-author)
• 10th International Symposium on GnRH-Hypothalamic-Pituitary-Gonadal Linkage in Cancer and Reproduction. Salzburg, Austria, 6-8 February 2011, conference website (co-authored);
• 27th Annual Meeting of the European Society of Human Reproduction and Embryology. Stockholm, Sweden, July 3-6, 2011, conference poster (co-author);
• 11th World Congress on Endometriosis. Montpellier, France, 4-7 September 2011, Conference Poster (co-authored)